BUDGET IMPACT ANALYSIS OF INDACATEROL/GLYCOPYRRONIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN COLOMBIA

被引：0
|
作者：
Patino, A. [1 ]
Karpf, E. [1 ]
Londono, D. [2 ]
机构：
[1] Novartis Colombia, Bogota, Colombia
[2] Fdn Santa Fe Bogota, Bogota, Colombia
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2662
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS6
引用
收藏
页码：A888 / A888
页数：1
相关论文
共 50 条
  • [21] COST-MINIMIZATION ANALYSIS AND BUDGET IMPACT OF GLYCOPYRRONIUM BROMIDE VERSUS TIOTROPIUM BROMIDE AS A MAINTENANCE BRONCHODILATOR TREATMENT IN PATIENTS WITH MODEREATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Ruiz Miranda, C., I
    Ubiarco Lopez, V
    Chavez Plascencia, E.
    VALUE IN HEALTH, 2015, 18 (03) : A174 - A174
  • [22] Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea
    Lee, Sang Haak
    Rhee, Chin Kook
    Yoo, Kwangha
    Park, Jeong Woong
    Yong, Suk Joong
    Kim, Jusang
    Lee, Taehoon
    Lim, Seong Yong
    Lee, Ji-Hyun
    Park, Hye Yun
    Moon, Minyoung
    Jung, Ki-Suck
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2021, 84 (02) : 96 - 104
  • [23] Indacaterol In Chronic Obstructive Pulmonary Disease
    Moen, Marit D.
    DRUGS, 2010, 70 (17) : 2269 - 2280
  • [24] BUDGET IMPACT ANALYSIS OF INDACATEROL IN THE TREATMENT OF COPD IN A FINNISH HOSPITAL DISTRICT
    Agthe, N.
    Purmonen, T.
    Kotaniemi, J.
    Kankaanranta, H.
    VALUE IN HEALTH, 2012, 15 (07) : A567 - A567
  • [25] Indacaterol/glycopyrronium vs tiotropium or glycopyrronium in treatment naive COPD patients: a pooled analysis
    Muro, Shigeo
    Yoshisue, Hajime
    Mackay, Alexander J.
    Kostikas, Konstantinos
    Olsson, Petter
    Gupta, Pritam
    Wedzicha, Jadwiga A.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [26] Once-daily glycopyrronium bromide (Seebri Breezhaler®) for the treatment of chronic obstructive pulmonary disease (COPD)
    Ulrik, Charlotte Suppli
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (17) : 2653 - 2659
  • [27] Coexisting Heart Failure and Chronic Obstructive Pulmonary Disease: Report of Two Cases Treated with Indacaterol/Glycopyrronium
    Cosentino, Eugenio Roberto
    Esposti, Daniela Degli
    Miceli, Rinaldo
    Bentivenga, Crescenzio
    Landolfo, Matteo
    Iamino, Ilaria Ricci
    Spinardi, Luca
    Magri, Gianluigi
    Borghi, Claudio
    RESPIRATION, 2018, 95 : 3 - 5
  • [28] Indacaterol/glycopyrronium (IND/GLY) is cost-effective compared with salmeterol/fluticasone (SFC) in Swedish chronic obstructive pulmonary disease (COPD) patients
    Bjermer, Leif
    van Boven, Job F. M.
    Costa-Scharplatz, Madlaina
    Gutzwiller, Florian S.
    Lisspers, Karin
    Mahon, Ronan
    van der Molen, Thys
    Olsson, Petter
    Roche, Nicolas
    Burke, Colin
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [29] ECONOMIC IMPACT OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN COLOMBIA
    Tamayo, C.
    Simbaqueba, E.
    Palomino, R. A.
    VALUE IN HEALTH, 2016, 19 (03) : A113 - A113
  • [30] Combination Therapy of Inhaled Indacaterol/Glycopyrronium for Chronic Obstructive Pulmonary Disease in the Very Elderly: Is It Safe? An Electrocardiographic Evaluation
    Spannella, Francesco
    Giulietti, Federico
    Cesari, Valentina
    Francioso, Antonio
    Cocci, Guido
    Landi, Laura
    Lombardi, Francesca Elena
    Borioni, Elisabetta
    Bernardi, Beatrice
    Rosettani, Giulia
    Bordoni, Valentina
    Iacoacci, Corrado
    Giordano, Piero
    Sarzani, Riccardo
    RESPIRATION, 2018, 95 : 22 - 29
12345